Trial By Fire releases SimpleTrials CTMS
Trial By Fire Solutions released its clinical trial management system (CTMS), SimpleTrials. It is available to help clinical study management as an on-demand CTMS, by including pricing and product information, and subscription capability on its website.
“The SimpleTrials team is proud to be leveling the field for clinical teams of all sizes and budgets with the first on-demand and most affordable CTMS available.” said Jon Cecchettini, co-founder and Chief Technology Officer at Trial By Fire Solutions. “We have leveraged a decade of experience building CTMS systems to bring this smart, elegant, and secure solution to teams that are challenged by the shortcomings of worksheet trackers or budget constraints.”
The SimpleTrials platform includes a feature set, flexibility for specific client and study needs, expert CTMS support, and a secure, validated hosting platform-all created to assist sponsors, CROs and sites with their study management needs.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Ethical, Biosafety, and Scientific Review Considerations in Hematology and Oncology Clinical Trials
September 10th 2024The current oncology and hematology drug development pipeline features a wide array of large molecule therapeutics. As a result, clinical trial protocols have grown more complex, requiring sponsors, CROs, and research sites to tackle a variety of challenges that were less common with older, more traditional therapies.
